AVITA Medical, Inc. (ASX:AVH)
1.625
+0.035 (2.20%)
Oct 15, 2025, 10:39 AM AEST
AVITA Medical Revenue
AVITA Medical had revenue of $18.42M USD in the quarter ending June 30, 2025, with 21.21% growth. This brings the company's revenue in the last twelve months to $74.88M, up 38.32% year-over-year. In the year 2024, AVITA Medical had annual revenue of $64.25M with 28.14% growth.
Revenue (ttm)
$74.88M
Revenue Growth
+38.32%
P/S Ratio
2.17
Revenue / Employee
$288.02K
Employees
260
Market Cap
247.91M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
Dec 31, 2022 | 34.42M | 1.40M | 4.23% |
Dec 31, 2021 | 33.03M | 3.79M | 12.98% |
Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 26.23M |
AVITA Medical News
- 1 day ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - PRNewsWire
- 5 days ago - AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders - GlobeNewsWire
- 6 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - PRNewsWire
- 11 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - PRNewsWire
- 11 days ago - AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm - GlobeNewsWire
- 13 days ago - AVITA Medical (RCEL) Secures NTAP Reimbursement for RECELL - GuruFocus
- 13 days ago - CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds - GlobeNewsWire
- 14 days ago - Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewsWire